[unable to retrieve full-text content]
CURE Pharmaceutical Expands US DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant NasdaqOXNARD, Calif., March 12, 2019-- CURE Pharmaceutical, an innovative drug delivery and development company, today announced it has broadened its U.S..
Read Again https://www.nasdaq.com/press-release/cure-pharmaceutical-expands-us-dea-approval-to-manufacture-pharmaceuticals-using-whole-cannabis-20190312-00292Bagikan Berita Ini
Related Posts :
Innovative, Removable Mesh Sling Now Available for Exclusive Manufacture - Richmond Register- Governor Ivey Announces Ecore International Plans Alabama Manufacturing Facility in $25 Million Project - Office of the Governor of Alabama - Governor Kay Ivey
- Honda and LG team up to manufacture EV batteries in the U.S. - pv magazine USA
- How the energy industry offers America a manufacturing revival - Washington Examiner
- Texas Manufacturing Outlook Survey - Dallasfed.org - Federal Reserve Bank of Dallas
0 Response to "CURE Pharmaceutical Expands US DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant - Nasdaq"
Post a Comment